带有白喉毒素易位结构域的模块化药物转运体在脂质膜上形成边缘孔洞。
Modular drug transporters with diphtheria toxin translocation domain form edged holes in lipid membranes.
作者信息
Khramtsov Yuri V, Rokitskaya Tatyana I, Rosenkranz Andrey A, Trusov Georgiy A, Gnuchev Nikolay V, Antonenko Yuri N, Sobolev Alexander S
机构信息
Department of Molecular Genetics of Intracellular Transport, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov St., Moscow, 119334, Russia.
出版信息
J Control Release. 2008 Jun 24;128(3):241-7. doi: 10.1016/j.jconrel.2008.03.011. Epub 2008 Mar 19.
Modular/chimeric recombinant drugs or drug transporters usually contain a special translocation domain from bacterial toxins, e.g. diphtheria toxin, as a module enabling escape of the chimeric molecules from acidifying endosomes. This approach is limited by the shortage in the knowledge about the precise molecular mechanisms of translocation of diphtheria toxin and the toxin-based chimera across the endosomal membrane and its release into the cytosol. We present experimental data with the modular recombinant drug transporters (MRTs), containing the translocation domain of diphtheria toxin, developed by us earlier, demonstrating that the MRTs interact with lipid membranes (liposomes, free-standing and supported bilayer lipid membranes) and produce defects in them at endosomal pH's which are sufficient for escape of macromolecules: - MRTs induced leakage of calcein-loaded liposomes pH 3-6.5. Large fluctuating conductance states of 2-5 nS are formed in membranes at pH 5.5. Atomic force microscopy revealed two different types of defects in the supported lipid bilayers at pH 5.5: 1) giant pores (50-200 nm diameters) and 2) small depressions/holes (30-50 nm) produced by the MRTs which are inserted into the membranes thus forming the structures described above. The last was shown with the use of cantilever tips modified with anti-MRT antibodies.
模块化/嵌合重组药物或药物转运体通常包含来自细菌毒素(如白喉毒素)的特殊转运结构域,作为使嵌合分子从酸化内体逃逸的模块。这种方法受到对白喉毒素和基于毒素的嵌合体跨内体膜转运及其释放到细胞质溶胶的确切分子机制认识不足的限制。我们展示了使用我们之前开发的包含白喉毒素转运结构域的模块化重组药物转运体(MRT)的实验数据,表明MRT与脂质膜(脂质体、自由悬浮和支撑双层脂质膜)相互作用,并在内体pH值下在其中产生足以使大分子逃逸的缺陷:- MRT在pH 3 - 6.5时诱导钙黄绿素负载脂质体泄漏。在pH 5.5时膜中形成2 - 5 nS的大波动电导状态。原子力显微镜显示在pH 5.5时支撑脂质双层中存在两种不同类型的缺陷:1)大孔(直径50 - 200 nm)和2)由插入膜中的MRT产生的小凹陷/孔(30 - 50 nm),从而形成上述结构。这是通过使用用抗MRT抗体修饰的悬臂尖端显示的。